The genomic profile of <i>HER2</i>‐amplified breast cancers: the influence of ER statusCaterina Marchiò, JS Reis‐Filho, SM Rodriguez‐Pinilla et al.|The Journal of Pathology|2008Cited by 75
Identification of novel determinants of resistance to lapatinib in ERBB2-amplified cancersDaniel Wetterskog, Alan Ashworth, K-K. Shiu et al.|Oncogene|2013Cited by 52